Medivir – funded and ready for further development

Premium News

2021-02-23

09:49

Medivir recently completed a rights issue of approx. SEK 195m before fees. The share is trading slightly above Redeye Bear Case. We've had a chat with analyst Niklas Elmhammer.

DM

David Madeling

Get Premium, Get Satisfied

Get this article and many more exclusive features with a premium membership. Full access to all articles.

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.